Human Milk Phospholipids Across Lactation Stages and Their Associations with Infant Neurodevelopment: A Prospective Cohort Study in China

Why It Matters

The study provides the first population‑level evidence that specific phospholipids in colostrum are linked to infant neurodevelopment, informing breastfeeding guidance and the design of lipid‑enriched infant formulas.

Key Takeaways

• Total phospholipids decline from colostrum to mature milk
• Higher colostrum LPC and ceramide link to better ASQ‑3 scores
• PI in 1‑month milk positively correlates with infant neurodevelopment
• Joint model shows ceramide, LPC, PC boost scores; PE reduces them
• Findings highlight colostrum’s lipid profile as a target for infant formula

Pulse Analysis

Early nutrition shapes the brain’s architecture, and human milk supplies a unique blend of phospholipids that serve as structural and signaling molecules for neuronal membranes. While animal studies have long suggested that milk‑derived phospholipids support myelination and synaptic plasticity, epidemiologic data linking these lipids to infant cognitive outcomes have been scarce. This gap is critical because phospholipids—especially lysophosphatidylcholine (LPC) and sphingolipids—carry essential fatty acids like DHA and choline, nutrients known to influence neurogenesis and neurotransmission during the first months of life.

The Frontiers in Nutrition study recruited 50 healthy mother‑infant pairs in Beijing, collecting milk at colostrum (2 days), transitional (15 days), 1‑month and 6‑month stages. Using UPLC‑MS/MS, researchers quantified 148 phospholipid species across 13 subclasses and assessed infant development with the Ages and Stages Questionnaires at six months. Advanced regression techniques, including Elastic Net with bootstrap resampling, pinpointed colostrum LPC and ceramide, as well as 1‑month phosphatidylinositol, as positive predictors of higher ASQ‑3 scores. Conversely, higher phosphatidylethanolamine was associated with lower scores. Joint multivariable modeling reinforced the beneficial role of ceramide, LPC and phosphatidylcholine, suggesting that early‑lactation lipid composition exerts measurable effects on neurodevelopmental trajectories.

These findings have practical implications for both public health and the infant formula industry. Promoting exclusive breastfeeding, particularly during the colostrum window, may maximize infants’ exposure to neuroprotective phospholipids. For formula manufacturers, the data support the strategic fortification of products with LPC, ceramide and choline‑rich phosphatidylcholine to more closely mimic the bioactive profile of early human milk. Future research should expand cohort sizes, extend follow‑up beyond six months, and explore mechanistic pathways through which specific phospholipids modulate brain signaling, paving the way for targeted nutritional interventions that enhance early cognitive outcomes.